GeneDx Holdings Corp.
WGS- Exchange
- Nasdaq
- Industry
- Services-Health Services
- SEC CIK
- 0001818331
In the last 90 days, GeneDx Holdings Corp. insiders filed 0 open-market purchases and 5 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $2.17B in total; ARK Invest is the only superinvestor holding it.
Holders of 5% or more of WGS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of GeneDx Holdings Corp., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| CMLS Holdings LLC | 13D/A | 17.90%5.36M shares | 0.00 ppfrom 17.90% | Feb 16, 202114 filings | May 22, 2026 | SEC |
| ARK Investment Management LLCSuperinvestorARK Invest | 13G/A | 6.42%1.91M shares | +1.09 ppfrom 5.33% | Jul 9, 20213 filings | Nov 13, 2026 | SEC |
| Goldman Sachs Group Inc | 13G | 5.80%1.73M shares | +1.90 ppfrom 3.90% | Feb 9, 20245 filings | Aug 11, 2026 | SEC |
| BlackRock, Inc. | 13G | 5.50%1.62M shares | New | Jul 28, 20261 filing | Jul 28, 2026 | SEC |
| William Blair Investment Management, LLC | 13G | 5.20%1.56M shares | +0.90 ppfrom 4.30% | Jul 30, 20253 filings | Nov 6, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
62 Schedule 13D and 13G filings on GeneDx Holdings Corp., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 202612:44 PM ET | ARK Investment Management LLCand 1 otherSuperinvestorARK Invest | 13G/A | 6.42%1.91M shares | +1.09 ppfrom 5.33% | Sep 30, 2026 | SEC |
| Nov 6, 202612:35 PM ET | William Blair Investment Management, LLC | 13G | 5.20%1.56M shares | +0.90 ppfrom 4.30% | Sep 30, 2026 | SEC |
| Aug 11, 20267:29 PM ET | Goldman Sachs Group Incand 1 other | 13G | 5.80%1.73M shares | +1.90 ppfrom 3.90% | Jun 30, 2026 | SEC |
| Aug 7, 20261:58 PM ET | ARK Investment Management LLCand 1 otherSuperinvestorARK Invest | 13G/A | 5.33%1.58M shares | – | Jul 31, 2026 | SEC |
| Jul 28, 20264:44 PM ET | BlackRock, Inc. | 13G | 5.50%1.62M shares | New | Jun 30, 2026 | SEC |
| May 22, 20265:20 PM ET | CMLS Holdings LLCand 8 others | 13D/A | 17.90%5.36M shares | 0.00 ppfrom 17.90% | May 20, 2026 | SEC |
| May 15, 20267:05 PM ET | CMLS Holdings LLCand 8 others | 13D/A | 17.90%5.36M shares | +1.20 ppfrom 16.70% | May 14, 2026 | SEC |
| May 11, 20269:20 PM ET | CMLS Holdings LLCand 8 others | 13D/A | 16.70%5.01M shares | +4.20 ppfrom 12.50% | May 7, 2026 | SEC |
| Nov 12, 20256:14 PM ET | William Blair Investment Management, LLC | 13G/A | 4.30%1.24M shares | −1.40 ppfrom 5.70%Below 5% | Sep 30, 2025 | SEC |
| Aug 26, 202511:27 AM ET | CMLS Holdings LLCand 8 others | 13D/A | 12.50%3.63M shares | −1.70 ppfrom 14.20% | Aug 22, 2025 | SEC |
| Aug 14, 202512:33 PM ET | Summit Partners Public Asset Management, LLCand 12 others | 13G/A | 3.04%867.3K shares | −2.15 ppfrom 5.19%Below 5% | Jun 30, 2025 | SEC |
| Aug 6, 202512:01 PM ET | FMR LLCand 1 other | 13G/A | 0.60%163.3K shares | −9.40 ppfrom 10.00%Below 5% | Jun 30, 2025 | SEC |
| Jul 30, 202512:19 PM ET | William Blair Investment Management, LLC | 13G | 5.70%1.63M shares | New | Jun 30, 2025 | SEC |
| May 12, 202510:32 AM ET | FMR LLCand 1 other | 13G | 10.00%2.79M shares | New | Mar 31, 2025 | SEC |
| May 9, 202512:28 PM ET | Goldman Sachs Group Incand 1 other | 13G/A | 3.90%1.11M shares | −1.30 ppfrom 5.20%Below 5% | Mar 31, 2025 | SEC |
| May 7, 20254:01 PM ET | CMLS Holdings LLCand 9 others | 13D/A | 14.20%4.10M shares | – | May 5, 2025 | SEC |
| Feb 21, 20254:30 PM ET | Icahn School of Medicine at Mount Sinaiand 1 other | 13D/A | 4.89%1.37M shares | −1.21 ppfrom 6.10%Below 5% | Feb 21, 2025 | SEC |
| Feb 18, 20258:01 PM ET | Icahn School of Medicine at Mount Sinaiand 1 other | 13D/A | 6.10%1.68M shares | – | Feb 18, 2025 | SEC |
| Feb 12, 20254:26 PM ET | Summit Partners Public Asset Management, LLCand 12 others | 13G | 5.19%1.43M shares | New | Feb 5, 2025 | SEC |
| Feb 5, 20254:05 PM ET | Goldman Sachs Group Incand 1 other | 13G | 5.20%1.42M shares | – | Dec 31, 2024 | SEC |
| Nov 20, 20249:36 PM ET | Opko Health, Inc. | 13D/AOld format | – | – | – | SEC |
| Nov 19, 2024 | Icahn School of Medicine at Mount Sinai | 13D/AOld format | – | – | – | SEC |
| Nov 8, 20245:23 PM ET | Opko Health, Inc. | 13D/AOld format | – | – | – | SEC |
| Nov 8, 2024 | Goldman Sachs Group Inc | 13G/AOld format | – | – | – | SEC |
| Nov 4, 2024 | Icahn School of Medicine at Mount Sinai | 13D/AOld format | – | – | – | SEC |
| Sep 18, 20244:13 PM ET | Opko Health, Inc. | 13D/AOld format | – | – | – | SEC |
| Aug 23, 20245:33 PM ET | Opko Health, Inc. | 13D/AOld format | – | – | – | SEC |
| Aug 12, 20246:27 PM ET | Opko Health, Inc. | 13D/AOld format | – | – | – | SEC |
| Jul 26, 20247:43 PM ET | Opko Health, Inc. | 13D/AOld format | – | – | – | SEC |
| Jul 5, 20244:14 PM ET | Opko Health, Inc. | 13D/AOld format | – | – | – | SEC |
| May 31, 2024 | CMLS Holdings LLC | 13D/AOld format | – | – | – | SEC |
| Feb 9, 2024 | Goldman Sachs Group Inc | 13GOld format | – | New | – | SEC |
| Nov 17, 2023 | CMLS Holdings LLC | 13D/AOld format | – | – | – | SEC |
| Jun 9, 2023 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Apr 20, 2023 | CMLS Holdings LLC | 13D/AOld format | – | – | – | SEC |
| Apr 20, 2023 | Opko Health, Inc. | 13D/AOld format | – | – | – | SEC |
| Feb 6, 2023 | Icahn School of Medicine at Mount Sinai | 13D/AOld format | – | – | – | SEC |
| Feb 3, 2023 | Blackstone Holdings III L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 3, 2023 | Opko Health, Inc. | 13D/AOld format | – | – | – | SEC |
| Feb 1, 2023 | Flynn James E | 13GOld format | – | – | – | SEC |
| Feb 1, 2023 | CMLS Holdings LLC | 13D/AOld format | – | – | – | SEC |
| Dec 5, 2022 | CMLS Holdings LLC | 13D/AOld format | – | – | – | SEC |
| Aug 17, 2022 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| May 9, 2022 | Opko Health, Inc. | 13DOld format | – | New | – | SEC |
| May 6, 2022 | Icahn School of Medicine at Mount Sinai | 13D/AOld format | – | – | – | SEC |
| May 3, 2022 | CMLS Holdings LLC | 13D/AOld format | – | – | – | SEC |
| May 3, 2022 | Blackstone Holdings III L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Integrated Core Strategies (US) LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Sachem Head Capital Management LP | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
58 notices from officers, directors and other affiliates planning to sell GeneDx Holdings Corp. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Sep 1, 20266:06 PM ET | Kevin FeeleyOfficer | 5.41K | $458.5K | Sep 1, 2026 | Morgan Stanley Smith Barney | SEC |
| Sep 1, 20266:05 PM ET | Katherine StuelandOfficer · Director | 14.2K | $1.21M | Sep 9, 2026 | Morgan Stanley Smith Barney | SEC |
| Apr 29, 20266:55 PM ET | Kevin FeeleyOfficer | 5.80K | $366.0K | Apr 29, 2026 | Morgan Stanley Smith Barney | SEC |
| Apr 29, 20266:53 PM ET | Katherine StuelandDirector · Officer | 16.4K | $1.04M | Apr 29, 2026 | Morgan Stanley Smith Barney | SEC |
| Feb 2, 20265:07 PM ET | Bryan DechairoOfficer | 9.37K | $929.9K | Feb 2, 202610b5-1 | Morgan Stanley Smith Barney | SEC |
| Jan 29, 20267:27 PM ET | Kevin FeeleyOfficer | 24.2K | $2.37M | Jan 29, 2026 | Morgan Stanley Smith Barney | SEC |
| Jan 29, 20267:25 PM ET | Katherine StuelandOfficer · Director | 94.5K | $9.27M | Jan 29, 2026 | Morgan Stanley Smith Barney | SEC |
| Nov 24, 20254:30 PM ET | Ruch JoshuaDirector | 38.0K | $6.09M | Nov 24, 2025 | Stifel Nicolaus & Company Inc | SEC |
| Sep 30, 20258:04 PM ET | Kevin FeeleyOfficer | 12.4K | $1.34M | Sep 30, 202510b5-1 | Morgan Stanley Smith Barney | SEC |
| Sep 30, 20258:04 PM ET | Katherine StuelandOfficer · Director | 29.3K | $3.16M | Sep 30, 202510b5-1 | Morgan Stanley Smith Barney | SEC |
| Aug 27, 20255:20 PM ET | Ryan JasonDirector | 39.2K | $4.99M | Aug 27, 2025 | Merrill Lynch | SEC |
| Aug 22, 20257:14 PM ET | Casdin Partners Master Fund, L.P.Affiliate | 500.0K | $60.5M | Aug 22, 2025 | Jefferies LLC | SEC |
| Jul 1, 20257:53 PM ET | Kevin FeeleyOfficer | 12.4K | $1.15M | Jul 1, 202510b5-1 | Morgan Stanley Smith Barney | SEC |
| Jul 1, 20257:53 PM ET | Katherine StuelandDirector · Officer | 29.3K | $2.69M | Jul 1, 202510b5-1 | Morgan Stanley Smith Barney | SEC |
| Jun 9, 20257:23 PM ET | Kevin FeeleyOfficer | 5.01K | $363.4K | Jun 9, 2025 | Morgan Stanley Smith Barney | SEC |
| Jun 9, 20257:22 PM ET | Katherine StuelandOfficer · Director | 14.1K | $1.03M | Jun 9, 2025 | Morgan Stanley Smith Barney | SEC |
| Jun 2, 20258:55 PM ET | Kevin FeeleyOfficer | 370 | $26.4K | Jun 2, 2025 | Morgan Stanley Smith Barney | SEC |
| Apr 29, 20259:52 PM ET | Kevin FeeleyOfficer | 388 | $43.9K | Apr 29, 2025 | Morgan Stanley Smith Barney | SEC |
| Apr 29, 20259:51 PM ET | Katherine StuelandDirector · Officer | 2.15K | $243.6K | Apr 29, 2025 | Morgan Stanley Smith Barney | SEC |
| Apr 14, 20258:00 PM ET | Icahn School Of Medicine At Mount SinaiShareholder | 500.0K | $50.5M | Apr 14, 2025 | Jefferies LLC | SEC |
| Apr 9, 20255:36 PM ET | Feeley KevinOfficer | 14.3K | $1.31M | Apr 9, 202510b5-1 | Merrill Lynch | SEC |
| Apr 9, 20255:10 PM ET | Stueland KatherineOfficer | 46.6K | $4.10M | Apr 9, 202510b5-1 | Merrill Lynch | SEC |
| Mar 26, 20256:36 PM ET | Kevin FeeleyOfficer | 8.75K | $836.2K | Mar 26, 2025 | Morgan Stanley Smith Barney | SEC |
| Mar 26, 20256:34 PM ET | Katherine StuelandDirector · Officer | 46.6K | $4.45M | Mar 26, 2025 | Morgan Stanley Smith Barney | SEC |
| Mar 17, 20256:46 PM ET | Kevin FeeleyOfficer | 3.75K | $362.6K | Mar 17, 2025 | Morgan Stanley Smith Barney | SEC |
Showing the latest 25. See the WGS notices from the last 12 months